About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility, SOMAÍ Pharmaceuticals, and indoor cultivation, NovaSoma, in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
For patients
FOR HEALTHCARE PROFESSIONALs
For partners
Global Company News
Digital Access or Illicit Return? Restricting Telemedicine Could Drive 42% Back to Underground: Industry Insiders Weigh In
“As Germany debates cracking down on tele-clinics and flower sales, all eyes are on patient experience disruptions,” Sassano said.“Reversing course…
Read more
149_Michael Sassano, Master Multi-Country Operator
From Wall Street to Lisbon, from real estate to cannabis pharmaceuticals — Michael Sassano’s journey is anything but ordinary. In this…
Read more
Australia’s White-Label Identity Crisis: A Story of Quality, Branding and Margins
As the medical cannabis industry in Australia continues to boom with more patients than ever and the most modern products…
Read more
The New Era of Cannabis in Switzerland, Open Access and Education Lead B SOMAÍ and Dascoli Pharma Partnership
Switzerland has long been a country that wants to create a safe and sustainable future for its population — and…
Read more
SOMAÍ and Lusófona University Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
Lisbon, Portugal — [1 July 2025] — SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines,…
Read more
SOMAÍ Launches New HCP Portals and AI Assistant as Part of Global Website Enhancements
SOMAÍ has announced the launch of dedicated HCP portals in Australia, Germany, and the United Kingdom, as well as the…
Read more
Precision Over Potency: Personalised Cannabis Medicine is Coming of Age
One of the key differences between medical cannabis and other more traditional treatments is the highly personalised nature of how…
Read more
Herer Legacy Goes Global: Dan Herer and Somai Pharmaceuticals Bring the Jack Herer Standard to the World
Dan Herer, son of the legendary Jack Herer, partners with Somai Pharmaceuticals to take the Herer standard worldwide. Blending grassroots…
Read more
How To Trade Cannabis Flower Globally: A Story Of Capital
The global medical cannabis markets are growing faster than we could have predicted, and new countries are expected to come…
Read more
Michael Sassano Talks Global Cannabis Markets, Regulatory Challenges, and Somai’s Vision from Sydney to Lisbon
Michael Sassano, CEO of Somai Pharmaceuticals, discusses global cannabis expansion, navigating regulations, and the future of cannabis products. Discover how…
Read more
Jack Herer Enters Global Pharma Market Through Partnership with SOMAÍ
The Jack Herer Brand, an iconic U.S.-based cannabis company, has announced a strategic partnership with SOMAÍ, a leading EU-GMP-certified vertically…
Read more
SOMAÍ Partners with SHERBINSKIS and BOUTIQ
A New Era for Medical Cannabis: SOMAÍ Teams Up with Iconic California Brands SHERBINSKIS and BOUTIQ for Europe and Australia…
Read more
Ireland Could Make Great Cannabis Policy: Examining the Past to Look Forward
Access to safe and controlled cannabis for the Irish people is being decided upon in 2025. Watching a country make…
Read more
Product Dumping, White Labels, and Conflicts of Interest Lead to Global Cannabis Price Catastrophe
2025 has kicked off fast and furious for the global cannabis industry as volumes increase and more countries come online…
Read more